Find the investors funding Health rounds
326,000+ VC, angel and family-office profiles — direct emails, check sizes and stage filters.
London-based Neobe raises €6.1 million to engineer bacteria that break down barriers protecting cancer tumours - EU-Startups
Neobe is a London-based company focused on engineering bacteria to break down the protective barriers surrounding cancer tumors. This funding will support their innovative approach to cancer treatment.
London-based Neobe raises €6.1 million to engineer bacteria that break down barriers protecting cancer tumours EU-Startups
| Nov 11, 2026 | Zodia Custody | $67.0M | Series A | United Kingdom |
| Nov 10, 2026 | Monzo | $630.0M | — | United Kingdom |
| Nov 08, 2026 | T-Therapeutics | $133.0M | Series B | United Kingdom |
| Nov 05, 2026 | Revolut | $115.00B | — | United Kingdom |
You just read who funded Neobe. The same database has the investors behind every other round — with verified emails, check sizes and the stages they actually write at.
Free account: 15 investor contact unlocks a month, no card required.